Role of Metabolism by Intestinal Bacteria in Arbutin-induced Toxicity In Vitro

被引:22
作者
Kang, Mi Jeong [1 ]
Ha, Hyun Woo [1 ]
Kim, Hyung Gyun [2 ]
Lee, Dae Hun [1 ]
Kong, Min Jeong [1 ]
Ahn, Young Tae [3 ]
Kim, Dong Hyun [4 ]
Shin, Beom Soo [5 ]
Kang, Wonku [1 ]
Jeong, Hye Gwang [2 ]
Jeong, Tae Cheon [1 ]
机构
[1] Yeungnam Univ, Coll Pharm, Gyongsan 712749, South Korea
[2] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
[3] Korea Yakult Co, Yongin 449901, South Korea
[4] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea
[5] Catholic Univ Daegu, Coll Pharm, Gyongsan 712702, South Korea
基金
新加坡国家研究基金会;
关键词
Bifidobacterium; Arbutin; Bacterial metabolism; Toxicity; Mammalian cell cultures; CLASSIFICATION; DISSOLUTION; MICROFLORA; DRUGS;
D O I
10.1007/s12272-011-0420-9
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A possible role of metabolism by intestinal bacteria in arbutin-induced toxicity was investigated in mammalian cell cultures. Following an incubation of arbutin with intestinal bacteria, either Bifidobacterium longum HY81 or Bifidobacterium adolescentis, for 24 h, its aglycone hydroquinone could be produced and detected in the bacterial culture media. The bacterial growth was not affected up to 10 mM arbutin in the culture medium. When the toxicity of bacteria cultured medium with arbutin was tested in the HepG2 cell lines, the medium with arbutin was more toxic than either parent arbutin only or bacteria cultured medium without arbutin, indicating that metabolic activation might be required in arbutin-induced toxicity. In addition, bacteria cultured medium with arbutin could suppress LPS and ConA mitogenicity in splenocyte cultures prepared from normal mice. The results indicate that the present toxicity testing system might be applied for assessing the possible role of metabolism by intestinal bacteria in certain chemical-induced toxicity in mammalian cell cultures.
引用
收藏
页码:687 / 693
页数:7
相关论文
共 12 条
[1]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]
Mutagenicity of arbutin in mammalian cells after activation by human intestinal bacteria [J].
Blaut, Michael ;
Braune, Annett ;
Wunderlich, Sandra ;
Sauer, Patrick ;
Schneider, Heiko ;
Glatt, Hansruedi .
FOOD AND CHEMICAL TOXICOLOGY, 2006, 44 (11) :1940-1947
[3]
Human exposure to naturally occurring hydroquinone [J].
Deisinger, PJ ;
Hill, TS ;
English, JC .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1996, 47 (01) :31-46
[4]
Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[5]
GORBACH SL, 1967, GASTROENTEROLOGY, V53, P845
[6]
JI GE, 1994, KOREAN J APPL MICROB, V22, P453
[7]
Effects of Gut Microflora on Pharmacokinetics of Hesperidin: A Study on Non-Antibiotic and Pseudo-Germ-Free Rats [J].
Jin, Ming Ji ;
Kim, Unyong ;
Kim, In Sook ;
Kim, Yuri ;
Kim, Dong-Hyun ;
Han, Sang Beom ;
Kim, Dong-Hyun ;
Kwon, Oh-Seung ;
Yoo, Hye Hyun .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2010, 73 (21-22) :1441-1450
[8]
The use of biopharmaceutic classification of drugs in drug discovery and development:: current status and future extension [J].
Lennernäs, H ;
Abrahamsson, B .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (03) :273-285
[9]
Characterization of fluids from the stomach and proximal jejunum in men and women [J].
Lindahl, A ;
Ungell, AL ;
Knutson, L ;
Lennernas, H .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :497-502
[10]
Gut instincts: Explorations in intestinal physiology and drug delivery [J].
McConnell, Emma L. ;
Fadda, Hala M. ;
Basit, Abdul W. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (02) :213-226